Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms modulating the activities of intestinal stem cells upon radiation or chemical agent exposure. | J Radiat Res | 2022 | 35021216 | PubTator, text mining | PubMed |
| Citrulline depletion by ASS1 is required for proinflammatory macrophage activation and immune responses. | Mol Cell | 2022 | 35016033 | PubTator, text mining | PubMed |
| Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology. | Nat Commun | 2022 | 35013236 | PubTator, text mining | PubMed |
| EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation. | Nat Commun | 2022 | 35013218 | PubTator, text mining | PubMed |
| N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner. | Bioengineered | 2022 | 35012429 | PubTator, text mining | PubMed |
| Amino Acid Metabolism in Cancer Drug Resistance. | Cells | 2022 | 35011702 | PubTator, text mining | PubMed |
| Induction and application of ferroptosis in cancer therapy. | Cancer Cell Int | 2022 | 34996454 | PubTator, text mining | PubMed |
| The effect of l-arginine supplementation and surgical trauma on the frequency of myeloid-derived suppressor cells and T lymphocytes in tumour and blood of colorectal cancer patients. | Adv Med Sci | 2022 | 34995935 | PubTator, text mining | PubMed |
| Integrated proteomic and metabolomic analyses of the mitochondrial neurodegenerative disease MELAS. | Mol Omics | 2022 | 34982085 | PubTator, text mining | PubMed |
| Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen receptors and Fos proto-oncogenes. | Bioengineered | 2022 | 34974814 | PubTator, text mining | PubMed |
| Bioinformatics analysis of candidate genes and potential therapeutic drugs targeting adipose tissue in obesity. | Adipocyte | 2022 | 34964707 | PubTator, text mining | PubMed |
| iTRAQ-based quantitative proteomics analysis of Sprague-Dawley rats liver reveals perfluorooctanoic acid-induced lipid metabolism and urea cycle dysfunction. | Toxicol Lett | 2022 | 34958885 | PubTator, text mining | PubMed |
| De Novo Arginine Synthesis Is Required for Full Virulence of Xanthomonas arboricola pv. juglandis During Walnut Bacterial Blight Disease. | Phytopathology | 2022 | 34941365 | PubTator, text mining | PubMed |
| Cancer metabolism and dietary interventions. | Cancer Biol Med | 2022 | 34931768 | PubTator, text mining | PubMed |
| Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker. | Alcohol | 2022 | 34923085 | PubTator, text mining | PubMed |
| The role of L-arginine metabolism in neurocritical care patients. | Neural Regen Res | 2022 | 34916417 | PubTator, text mining | PubMed |
| p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance. | Oncogene | 2022 | 34907345 | PubTator, text mining | PubMed |
| An Investigation of the Knowledge Overlap between Pharmacogenomics and Disease Genetics. | Pac Symp Biocomput | 2022 | 34890165 | PubTator, text mining | PubMed |
| [Loss of visual acuity after vaccination?] | Ophthalmologie | 2022 | 34878595 | PubTator, text mining | PubMed |
| Characteristics of subjective cognitive decline associated with amyloid positivity. | Alzheimers Dement | 2022 | 34877782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=45